Hiroki Izumi
0000-0002-9566-4859
Hino Hospital
2 papers found
Refreshing results…
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation
Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study
Missing publications? Search for publications with a matching author name.